Literature DB >> 24393279

Endovascular recanalization of infrapopliteal occlusions in patients with critical limb ischemia.

Gagan D Singh1, Ehrin J Armstrong1, Khung-Keong Yeo2, Satinder Singh1, Gregory G Westin1, William C Pevec3, David L Dawson3, John R Laird4.   

Abstract

BACKGROUND: Endovascular therapies are increasingly used for treatment of critical limb ischemia (CLI). Infrapopliteal (IP) occlusions are common in CLI, and successful limb salvage may require restoration of arterial flow in the distribution of a chronically occluded vessel. We sought to describe the procedural characteristics and outcomes of patients with IP occlusions who underwent endovascular intervention for treatment of CLI.
METHODS: All patients with IP interventions for treatment of CLI from 2006 to 2012 were included. Angiographic and procedural data were compared between patients who underwent intervention for IP occlusions vs IP stenosis. Restenosis was determined by Doppler ultrasound imaging. Limb salvage was the primary end point of the study. Additional end points included primary patency, primary assisted patency, secondary patency, occlusion crossing success, procedural success, and amputation-free survival.
RESULTS: A total of 187 patients with CLI underwent interventions for 356 IP lesions, and 77 patients (41%) had interventions for an IP occlusion. Patients with an intervention for IP occlusion were more likely to have zero to one vessel runoff (83% vs 56%; P < .001) compared with interventions for stenosis. Compared with IP stenoses, IP occlusions were longer (118 ± 86 vs 73 ± 67 mm; P < .001) and had a smaller vessel diameter (2.5 ± 0.8 vs 2.7 ± 0.5 mm; P = .02). Wire crossing was achieved in 83% of IP occlusions, and the overall procedural success for IP occlusions was 79%. The overall 1-year limb salvage rate was 84%. Limb salvage was highest in the stenosis group, slightly lower in the successful occlusion group, and lowest in the failed occlusion group (92% vs 75% vs 58%, respectively; P = .02). Unsuccessfully treated IP occlusions were associated with a significantly higher likelihood of major amputation (hazard ratio, 5.79; 95% confidence interval, 1.89-17.7) and major amputation or death (hazard ratio, 2.69; 95% confidence interval, 1.09-6.63).
CONCLUSIONS: Successful endovascular recanalization of IP occlusions can be achieved with guidewire and support catheter techniques in most patients. In patients selected for an endovascular-first approach for IP occlusions in CLI, this strategy can be successfully implemented with favorable rates of limb salvage.
Copyright © 2014 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24393279      PMCID: PMC4004651          DOI: 10.1016/j.jvs.2013.11.061

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  35 in total

1.  Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions.

Authors:  D Scheinert; J R Laird; M Schröder; H Steinkamp; J O Balzer; G Biamino
Journal:  J Endovasc Ther       Date:  2001-04       Impact factor: 3.487

2.  Technical and clinical long-term results of infrapopliteal percutaneous transluminal angioplasty for critical limb ischemia.

Authors:  Henk Odink; Aaike van den Berg; Bjorn Winkens
Journal:  J Vasc Interv Radiol       Date:  2012-02-01       Impact factor: 3.464

3.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

4.  Recommended standards for reports dealing with lower extremity ischemia: revised version.

Authors:  R B Rutherford; J D Baker; C Ernst; K W Johnston; J M Porter; S Ahn; D N Jones
Journal:  J Vasc Surg       Date:  1997-09       Impact factor: 4.268

5.  Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial.

Authors:  Andrew J Feiring; Mari Krahn; Lori Nelson; Amy Wesolowski; Daniel Eastwood; Aniko Szabo
Journal:  J Am Coll Cardiol       Date:  2010-04-13       Impact factor: 24.094

6.  Critical limb ischemia.

Authors:  Andres Schanzer; Michael S Conte
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04-14

Review 7.  Overview of new technologies for lower extremity revascularization.

Authors:  Jason H Rogers; John R Laird
Journal:  Circulation       Date:  2007-10-30       Impact factor: 29.690

Review 8.  Infrapopliteal stents: overview and unresolved issues.

Authors:  Dimitris Karnabatidis; Konstantinos Katsanos; Dimitris Siablis
Journal:  J Endovasc Ther       Date:  2009-02       Impact factor: 3.487

9.  Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia.

Authors:  Marcello Romiti; Maximiano Albers; Francisco Cardoso Brochado-Neto; Anai Espinelli S Durazzo; Carlos Alberto Bragança Pereira; Nelson De Luccia
Journal:  J Vasc Surg       Date:  2008-04-18       Impact factor: 4.268

10.  Clinical outcomes of infrapopliteal angioplasty in patients with critical limb ischemia.

Authors:  Hyeon Min Ryu; Jung-Sun Kim; Young Guk Ko; Myeong-Ki Hong; Yangsoo Jang; Donghoon Choi
Journal:  Korean Circ J       Date:  2012-04-26       Impact factor: 3.243

View more
  2 in total

Review 1.  Endovascular Treatment of Infrapopliteal Peripheral Artery Disease.

Authors:  Ehrin J Armstrong; Kalkidan Bishu; Stephen W Waldo
Journal:  Curr Cardiol Rep       Date:  2016-04       Impact factor: 2.931

Review 2.  Percutaneous versus surgical management of lower extremity peripheral artery disease.

Authors:  Amit M Kakkar; J Dawn Abbott
Journal:  Curr Atheroscler Rep       Date:  2015       Impact factor: 5.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.